Global efforts to expand access to life-saving HIV prevention medicines have received a major boost after the Global Fund to Fight AIDS, Tuberculosis and Malaria announced new measures to increase supply and reach millions more people worldwide. The move, supported by the United States Government and pharmaceutical company Gilead Sciences, focuses on expanding access to
The Ministry of Health, through the Pharmacy and Poisons Board, has recommended the registration of Lenacapavir, a long-acting antiretroviral medicine for HIV pre-exposure prophylaxis (PrEP). In a statement dated Saturday, 10, 2026, Health CS Aden Duale stated that the approval covers Lenacapavir 300 mg tablets and Lenacapavir 464 mg injectable solution. “The Ministry of Health,
Popular Posts
